Coronary artery disease
A long-term heart condition in which fatty deposits narrow the arteries that feed the heart. It can cause chest pain and breathlessness during activity, but some people have no signs until a heart attack. It cannot be cured, but lifestyle changes, medicines and procedures can ease the symptoms and lower the risk of a heart attack. The risk rises with age, and men tend to get it earlier than women.
Read more about coronary artery diseaseTrial-stage treatments and research studies you can join
Filters
- Treating heavily calcified heart arteries and effects on tiny blood vessels
Tests how treating calcified heart arteries affects tiny blood vessels.
Katowice, PolandAge 18+ - Dissolving Magnesium Scaffold Compared With a Drug-Coated Stent for Narrowed Heart Arteries
Compares a dissolving magnesium scaffold with the Xience stent in adults with coronary artery disease.
Lubin, PolandAge 18 to 80 - Tests a sirolimus-releasing stent in people with coronary artery disease
Tests a drug-releasing heart artery stent in adults with narrowed coronary arteries.
Lubin, PolandAge 18+ - Blood-thinning medicines after bypass surgery in people with stable heart disease
Compares aspirin doses and prasugrel with aspirin in adults having bypass surgery.
Bialystok, PolandAlso Gdansk, Grudziądz, Katowice, Lodz, Olsztyn, Opole, Poznan, Szczecin, …Age 18+ - RBD1119 injections in people with stable coronary artery disease
Tests RBD1119 against placebo for safety in people with stable coronary artery disease.
Gdynia, PolandAlso Grodzisk Mazowiecki, Krakow, Lubin, Lublin, Warsaw, ZamośćAge 50+ - Comparing two shockwave devices for calcified coronary artery disease
Compares ShockFast and ShockWave devices for calcium-hardened heart arteries in adults.
Katowice, PolandAlso Krakow, Lubin, WroclawAge 18+ - Tests clazakizumab in adults with kidney failure on dialysis
Tests clazakizumab against placebo in dialysis patients with heart disease or diabetes and inflammation.
Brodnica, PolandAlso Katowice, Łęczna, Lodz, Pszczyna, Stalowa Wola, Szczecin, Tczew, WarsawAge 18+ - Tests inclisiran started early after hospital admission for serious heart conditions
Compares inclisiran with placebo, alongside standard care, in adults with acute coronary syndromes.
Gdansk, PolandAlso Katowice, Krakow, OpoleAge 18+ - Tests invobenitug in adults with cardiogenic shock and raised DPP3 levels
Tests invobenitug against placebo in adults with life-threatening cardiogenic shock.
Bialystok, PolandAlso Katowice, Poznan, WroclawAge 18 to 80 - Comparing blood thinners and treatment length after a heart attack with a stent
Compares prasugrel with ticagrelor, and shorter with longer treatment, after a heart attack.
Krakow, PolandAge 18+ - Drug-Coated Balloons for Heart Attacks Caused by Plaque Erosion
Compares drug-coated balloon treatment with medicines in adults having a heart attack from plaque erosion.
Lubin, PolandAge 18+ - Tests a new bypass graft device during heart bypass surgery
Tests a new bypass graft in adults with blocked heart arteries needing surgery.
Krąków, PolandAlso WarsawAge 18+ - Tests a new tissue-engineered blood vessel for heart bypass surgery
Tests a lab-made blood vessel in adults with multi-vessel coronary artery disease needing bypass surgery.
Poznan, PolandAlso Szczecin, WarsawAge 45 to 75 - Tests dabigatran with ticagrelor in adults with atrial fibrillation after heart stenting
Tests two blood thinners in adults with irregular heartbeat after acute coronary syndrome and stenting.
Bialystok, PolandAlso Bydgoszcz, Chrzanów, Elblag, Gdansk, Katowice, Olsztyn, Opole, Toruń, …Age 18+ - Flu Vaccination Before Hospital Discharge for People With Acute Heart Conditions
Tests giving a flu vaccine just before discharge in adults hospitalized for heart conditions.
Wroclaw, PolandAge 18+ - Tests whether a defibrillator device is needed after a heart attack
Tests a defibrillator device against medicines alone in adults with weak hearts after heart attack.
Rzeszów, PolandAlso Warsaw, ZabrzeAge 18+ - Tests orticumab for inflammation in heart arteries after a heart attack
Tests orticumab against placebo in adults with prior heart attack and arterial inflammation.
Krakow, PolandAlso Warsaw, WroclawAge 18+ - Paclitaxel-coated balloon for blocked coronary arteries during stent-free widening
Tests a paclitaxel-coated balloon in adults with fully blocked heart arteries.
Warsaw, PolandAge 18+ - Coated balloons versus drug stents for heart artery branch blockages
Compares drug-coated balloons with drug-releasing stents in adults with coronary artery disease at a split.
Gdansk, PolandAlso Katowice, Krakow, Lubin, Lublin, Poznan, Rzeszów, Wałbrzych, Warsaw, …Age 18+ - Comparing diabetes drugs for coronary artery plaque in people with pre-diabetes
Tests semaglutide or dapagliflozin against metformin for artery plaque in pre-diabetes.
Warsaw, PolandAge 18 to 80
Where treatment stands
There is no cure for coronary artery disease, but treatment can help manage the symptoms and lower the chance of problems such as heart attacks.
In the EU, colchicine was first approved in July 2026, not necessarily for this disease.
Approved: 71
Officially approved for this disease in the EU, the US, Switzerland or France.
Human testing stage: 31
Being tested in people. Many treatments at this stage are never approved.
Animal testing stage: 5
Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.
Placebo: a dummy treatment without the medicine, used for comparison.
Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.
The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.
A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.
The trials: ClinicalTrials.gov and the EU trials register, as copied into our trial database, checked on 12 November 2026. Every treatment in trials links to its own trial records; the texts are written by AI from them and checked against them by a second AI. People have not reviewed them yet. Placebo, standard medicines used for comparison and procedures are left out.
Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 46 other open phase 2 trials are not listed.
Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for coronary artery disease. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.
Not medical advice. Talk to your doctor before you change any treatment.
The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.
Support organisations
Patient organisations and helplines in Poland, for you and your family.
Coronary artery disease organisations in Poland
- Ogólnopolskie Stowarzyszenie Pacjentów ze Schorzeniami Serca i Naczyń "EcoSerce"
Support for cardiac patients and families: debates, workshops, information campaigns and patient-rights advocacy.
- Serce na Banacha
Patient advocacy, health education and work toward equal access to modern cardiology care.
General support in Poland
- Centrum Wsparcia dla osób dorosłych w kryzysie psychicznym
Free 24/7 support line (800 70 2222) and chat for adults in psychological crisis in Poland, funded by the Ministry of Health.
- pacjent.gov.pl
Patient portal of the Polish Ministry of Health and National Health Fund with reliable, verified information on health and the care system.
- Rzecznik Praw Pacjenta
Poland's central government Patient Ombudsman protecting patient rights, with a free patient helpline (800 190 590).
International organisations
Offer tissue or data
There are three ways to help research move faster.
Approved treatments
75 medicines are approved for coronary artery disease in at least one of the places we checked. An approval in one place does not mean the medicine is offered or paid for where you live.
Checked on 11 Nov 2026 in the official lists of the US (FDA), the EU (EMA), Japan (PMDA, approvals since April 2004), Switzerland (Swissmedic), France (ANSM, medicines approved in France only) and Taiwan (TFDA). For Canada (Health Canada) and Singapore (HSA) we checked only whether a medicine is sold there, not what for. 24 uncertain matches are left out. Other countries' own approvals were not checked.
“Miracle cure” fact checker
Social media spreads misinformation. Paste what you read here, and we'll tell you whether there is scientific evidence behind it.
What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.
Before you pay for anything, ask three things
- Is there a published study in people?
- Can I have the full price in writing?
- What does my doctor say?
“Cures” others already fact-checked
- Omega-3 fatty acids (fish oil) & Coronary artery disease
- Curcumin (turmeric) & Coronary artery disease
- Stem cell treatment & Coronary artery disease
- CBD (cannabidiol) & Coronary artery disease
About coronary artery disease
Sources: NHS, MedlinePlus
A long-term heart condition in which fatty deposits narrow the arteries that feed the heart. It can cause chest pain and breathlessness during activity, but some people have no signs until a heart attack. It cannot be cured, but lifestyle changes, medicines and procedures can ease the symptoms and lower the risk of a heart attack. The risk rises with age, and men tend to get it earlier than women.
What is it?
The coronary arteries carry blood and oxygen to the heart muscle. Over the years, fatty deposits containing cholesterol build up inside their walls (atherosclerosis). The arteries narrow, so the heart gets less blood than it needs, and a blockage can cause a heart attack. In some people, the heart's tiny blood vessels are damaged instead; this type is more common in women.
It is the most common type of heart disease in the United States and a leading cause of death for both men and women. The risk rises with age, and men tend to get it earlier. Smoking, high blood pressure, high cholesterol, diabetes, obesity and too little activity raise the risk. It runs in families: the risk is higher if a parent, brother or sister had heart disease before 50.
The first signs
Some people have no signs, and only find out when they have a heart attack. Signs may start or get worse when you are active or under stress, and may go away with rest.
- chest pain, pressure or tightness (angina);
- pain that spreads to the neck, jaw, shoulders or arms;
- shortness of breath;
- unusual tiredness, feeling faint or feeling sick.
Chest pain that does not go away, or that comes on at rest, may be a heart attack: call the emergency number straight away.
How doctors find out
Your doctor asks about your symptoms, your family and your lifestyle, checks your blood pressure, and does blood tests for cholesterol and sugar. A risk score can estimate your chance of a heart attack or stroke in the next 10 years. Tests that can confirm it include an ECG, an echocardiogram, a chest X-ray, and a coronary angiogram, which is an X-ray that checks the blood vessels.
Current treatment
Treatment combines lifestyle changes with medicines such as blood thinners, statins and blood pressure medicines, and some people also need angioplasty with a stent or bypass surgery.
Will it get worse?
The symptoms can get worse over time as more fatty deposits build up. Over time it can lead to angina, a heart attack, heart failure or an irregular heartbeat. A healthy lifestyle may slow the disease down, and treatment can help reduce the chances of problems such as a heart attack.
Medicines: what helps, and what to watch for
Many different medicines are used to treat heart disease. Blood thinners such as low-dose aspirin or clopidogrel stop clots forming and lower the risk of a heart attack. Statins lower cholesterol. Beta blockers slow the heartbeat and help with angina. Nitrates widen the blood vessels and ease chest pain. Other medicines lower blood pressure.
Good to know:
- nitrates can cause mild headaches, dizziness and flushed skin;
- ACE inhibitors, such as ramipril, can cause a dry cough and dizziness, and you need regular blood tests to check your kidneys;
- calcium channel blockers can cause headaches and a flushed face, which are usually mild and short-lived.
Exercise and therapy help too
- cardiac rehabilitation after a heart attack: often weekly sessions that last 6 to 12 weeks, in a group, online or at home, with suitable exercise, advice on taking your medicines, stress management and support for anxiety and low mood;
- people who go to cardiac rehabilitation are less likely to have another heart attack or go into hospital;
- be active, eat a healthy, balanced diet and keep a healthy weight;
Procedures and surgery, for some people
In a coronary angioplasty, a small balloon pushes the fatty deposits outwards to widen a narrowed artery, and a small metal tube (stent) is usually left in to keep it open. It can be planned, or done urgently during a heart attack. In bypass surgery, a blood vessel is attached so that blood can flow around the narrowed or blocked part. Occasionally a heart transplant may be needed, when the heart is severely damaged and medicines do not work, or when the heart cannot pump enough blood.
Is there a cure?
No. Coronary heart disease cannot be cured, but treatment eases the symptoms and lowers the chance of a heart attack.
Sources
Written in plain words by Frontlight from these pages: